Method of treatment with IL-9 conjugate
US6645486B1 · kind B1 · utility
3Cited by
3References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 25, 2000 |
| Grant date | Nov 11, 2003 |
| Priority date | — |
| Expiry date | Jan 25, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/6081
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The methods of this invention relate to immunizing animals with conjugates of cytokines and a carrier to induce a prolonged high titre antibody response specific for the cytokine. This invention also relates to the treatment of pathological conditions, e.g., eosinophilia and allograft rejection, associated with the production of cytokines, in particular interleukins, e.g., IL-4, IL-5, IL-9, and IL-13, by immunization with the cytokine conjugates or by administration of antibodies specific for the cytokine. This invention also relates to compositions comprising the cytokine conjugates and the conjugates per se.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.